Aumet for Healthcare Technology Raises $7M In Pre-Series A
Aumet for healthcare technology has successfully raised $7 million in a Pre-Series A funding round. The funding was from a range of global investors.
The company’s AI-enabled platform provides tailored solutions to pharmacists and other health providers. It uses predictive analysis to forecast the procurement of products for pharmacies.
Aumet’s funding round and investors
Aumet has raised the funding from a range of global investors, including healthcare investors and pharmaceutical conglomerates.
These investors include Tokyo-based healthcare-focused venture capital firm AAIC. As well as, Swiss private equity firm AIJ Holdings, Tijah Holdings, Hamad Ali Sagri family office, Cigalah Group. In addition to Aumet’s early backer Shorooq Partners, who previously invested in Aumet during its pre-seed and seed stages.
This funding round marks a significant milestone for Aumet, as it looks to expand its reach and capabilities in this industry.
Aumet’s AI-Enabled B2B Healthcare Platform
Aumet’s AI-enabled platform provides solutions to healthcare providers using predictive analytics to forecast the procurement of products for pharmacies.
This results in significant cost savings and greater efficiencies in the supply chain of pharmacies.
The platform also facilitates the exchange of data between healthcare providers, manufacturers, and distributors to help them make informed decisions.
Aumet serves over 10,000 pharmacies across three core markets, including Saudi Arabia, Jordan, and Egypt.
Aumet’s Plans for the Future
With the proceeds from this funding round, Aumet plans to develop its AI capabilities further. In addition to expanding its reach to more pharmacies, and provide greater access to affordable medical products for consumers.
Aumet aims to achieve its promise of “securing the lives of a billion of people by digitizing the medicine and medical procurement cycle globally.”
Aumet’s commitment to providing affordable healthcare products will undoubtedly have a positive impact on the lives of many people across the globe.
Aumet’s Impact on the Industry
The healthcare industry in the Middle East and North Africa (MENA) region has seen significant growth in recent years, with forward-looking innovations and transformations.
Aumet is at the forefront of this industry, providing tailored solutions to healthcare providers and improving the efficiency of the supply chain.
The company’s innovative approach and commitment to providing affordable healthcare products will undoubtedly have a positive impact on the healthcare industry.
A Bright Future for Aumet
In conclusion, Aumet’s successful funding round and innovative solutions indicate a bright future for the company. The company’s commitment to providing affordable medical products and its innovative approach to this industry will undoubtedly have a positive impact on the lives of many people across the globe.
With its plans for expansion and further development, Aumet is set to make a significant impact on the industry in the coming years.
